Poland
· Delayed Price · Currency is PLN Medinice Statistics
Total Valuation
Medinice has a market cap or net worth of PLN 72.38 million. The enterprise value is 67.87 million.
| Market Cap | 72.38M |
| Enterprise Value | 67.87M |
Important Dates
The last earnings date was Friday, September 27, 2024.
| Earnings Date | Sep 27, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Medinice has 6.46 million shares outstanding. The number of shares has increased by 2.57% in one year.
| Shares Outstanding | 6.46M |
| Shares Change (YoY) | +2.57% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 38.31% |
| Owned by Institutions (%) | 13.94% |
| Float | 2.47M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 2.31 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -14.31 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -18.09 |
Financial Position
The company has a current ratio of 4.49, with a Debt / Equity ratio of 1.94.
| Current Ratio | 4.49 |
| Quick Ratio | 4.49 |
| Debt / Equity | 1.94 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.16 |
| Interest Coverage | -81.92 |
Financial Efficiency
Return on equity (ROE) is -14.21% and return on invested capital (ROIC) is -9.82%.
| Return on Equity (ROE) | -14.21% |
| Return on Assets (ROA) | -8.74% |
| Return on Capital (ROIC) | -9.82% |
| Revenue Per Employee | 13,813 |
| Profits Per Employee | -296,313 |
| Employee Count | 16 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -4.27% in the last 52 weeks. The beta is 1.11, so Medinice's price volatility has been higher than the market average.
| Beta (5Y) | 1.11 |
| 52-Week Price Change | -4.27% |
| 50-Day Moving Average | 10.96 |
| 200-Day Moving Average | 9.61 |
| Relative Strength Index (RSI) | 43.91 |
| Average Volume (20 Days) | 11,007 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medinice had revenue of PLN 221,000 and -4.74 million in losses. Loss per share was -0.73.
| Revenue | 221,000 |
| Gross Profit | 81,000 |
| Operating Income | -5.33M |
| Pretax Income | -4.74M |
| Net Income | -4.74M |
| EBITDA | -5.17M |
| EBIT | -5.33M |
| Loss Per Share | -0.73 |
Balance Sheet
The company has 5.12 million in cash and 609,000 in debt, giving a net cash position of 4.51 million or 0.70 per share.
| Cash & Cash Equivalents | 5.12M |
| Total Debt | 609,000 |
| Net Cash | 4.51M |
| Net Cash Per Share | 0.70 |
| Equity (Book Value) | 31.34M |
| Book Value Per Share | 4.85 |
| Working Capital | 4.58M |
Cash Flow
In the last 12 months, operating cash flow was -3.73 million and capital expenditures -19,000, giving a free cash flow of -3.75 million.
| Operating Cash Flow | -3.73M |
| Capital Expenditures | -19,000 |
| Free Cash Flow | -3.75M |
| FCF Per Share | -0.58 |
Margins
| Gross Margin | 36.65% |
| Operating Margin | -2,409.50% |
| Pretax Margin | -2,145.25% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -1,697.74% |
Dividends & Yields
Medinice does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.57% |
| Shareholder Yield | -2.57% |
| Earnings Yield | -6.55% |
| FCF Yield | -5.18% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Medinice has an Altman Z-Score of 8.4.
| Altman Z-Score | 8.4 |
| Piotroski F-Score | n/a |